Micah Zajic

43 year

Health Technology

Consumer Services

Profile

Mr. Micah Zajic was previously employed as a Chief Business Officer by Lexeo Therapeutics, Inc., a Chief Financial Officer by SQZ Biotechnologies Co., a Vice President-Corporate Development by MeiraGTx Ltd., and a Senior Director-Corporate Strategy by Alexion Pharmaceuticals, Inc. He received his undergraduate degree from Georgetown University.

Former positions of Micah Zajic

Companies	Position	End
LEXEO THERAPEUTICS, INC.	Director of Finance/CFO	2023-06-30
SQZ BIOTECHNOLOGIES COMPANY	Director of Finance/CFO	2022-12-30
MeiraGTx Ltd. MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom.	Corporate Officer/Principal	2020-08-31
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	2017-03-31

See the detail of Micah Zajic's experience

Training of Micah Zajic

Georgetown University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Micah Zajic's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SQZ BIOTECHNOLOGIES COMPANY	Health Technology
LEXEO THERAPEUTICS, INC.	Health Technology

Private companies	2
MeiraGTx Ltd. MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom.	Health Technology
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology